|
|
Macroscopic images (left) have a square open box centered on the area with most concentrated PTEN-null glands. A curved arc identifies a fragment of tissue containing the greatest concentration of PTEN-null glands which was used for morphometry, and appears in the "bullseye" view, and other photomicrographs. Point counting morphometry was performed within a 1mm circular sample window of the PTEN-immunostained slide, as represented in the "Bullseye" image, and resultant parameters appear below. Dx: Diagnosis, pe=normal proliferative; anov=anovulatory, persistent proliferative; ein= EIN precancer Morphometry: (yes) if fragment size and condition suited to measurement. (No) if fragmented. Vol. % stroma: Volume percentage stroma, fraction of sample fragment occupied by stroma. Null G. Vol. %: Volume percentage null gland,tissue % occupied by PTEN non-expressing glands. Pos G. Vol. %: Volume percentage positive gland,tissue % occupied by PTEN expressing glands. Null G, #/mm2: Density of PTEN-null glands, number per mm2 of tissue Pos G, #/mm2: Density of PTEN-expressing glands, number per mm2 of tissue mm2 per null: Average size of a single PTEN-null glands, mm2/per gland mm2 per pos: Average size of a single PTENexpressing gland, mm2/per gland Age: in years at time of sampling Hormone: (yes) on hormone replacement, or (no) Indication: reported reason for sampling Symptoms: Physical symptoms and/or sign preceding sampling Menopause: (pre), (peri) or (post) menopausal based upon age, history, and evidence of endogenous hormonal activity
REFERENCE: 1)Mutter
GL, Ince TA, Baak JPA, Kust G, Zhou X, Eng C: Molecular identification of latent
precancers in histologically normal endometrium. Cancer Res, 61(11). In
Press for June 1, 2001 issue. |
Copyright 1998-2008 by George L. Mutter, MD. All Rights Reserved
|